Stocks
Ionis Pharmaceuticals, Inc.IONS
NASDAQHealthcareBiotechnology$71.19-1.59%
Focused on RNA-targeted drug development, this biotechnology company develops antisense therapies designed to treat rare and serious diseases by altering the production of disease-causing proteins. Its business model combines an internal clinical pipeline with licensing partnerships that generate mi...
Market Cap: $11.8B52W Range: $23.95 – $86.74
Congressional Interest in Ionis Pharmaceuticals, Inc. (IONS)
6 members of Congress have disclosed 12 trades in Ionis Pharmaceuticals, Inc. (IONS), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
6
Buys
8
Sells
4
Who in Congress Is Trading IONS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-09-13 | Rohit Khanna | buy | $1K – $15K |
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |